Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15412880 | 0.98 | TSHR (0.50) | TSHRAPPPTGS1PDE4ALMNA | |
| SCHEMBL20514341 | 0.94 | TSHR (0.50) | TSHRAPPPTGS1PDE4ALMNA | |
| SCHEMBL11079760 | 0.87 | TSHR (0.45) | TSHRAPPPTGS1PDE4ALMNA | |
| SCHEMBL421993 | 0.79 | APP (0.50) | TSHRAPPPTGS1PDE4ALMNA | |
| SCHEMBL15412165 | 0.79 | TSHR (0.47) | TSHR | |
| SCHEMBL18071751 | 0.79 | TSHR (0.47) | TSHRLMNA | |
| SCHEMBL15252849 | 0.78 | TSHR (0.46) | TSHRLMNACA12CA1CA2 | |
| SCHEMBL25299218 | 0.77 | APP (0.48) | TSHRAPPPTGS1PDE4ALMNA | |
| SCHEMBL20875302 | 0.77 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL19640302 | 0.77 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108291307-B | Plating bath composition and method for electroless plating of palladium | 埃托特克德国有限公司 | 2020-02-14 | — | — | CN | claimed |
| US-10513780-B2 | Plating bath composition and method for electroless plating of palladium | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-12-24 | — | — | US | claimed |
| EP-3380649-B1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-10-30 | — | — | EP | claimed |
| US-20180340260-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2018-11-29 | — | — | US | claimed |
| EP-3380649-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH Deutschland GmbH (DE) | 2018-10-03 | — | — | EP | claimed |
| WO-2022017442-A1 | BIFUNCTIONAL PROTEIN DEGRADATION-TARGETED CHIMERA COMPOUND, PREPARATION METHOD THEREFOR AND MEDICINAL USE THEREOF | 恩瑞生物医药科技（上海）有限公司 | 2022-01-27 | — | — | WO | disclosed |
| US-10858747-B2 | Acidic zinc and zinc nickel alloy plating bath composition and electroplating method | ATOTECH DEUTSCHLAND GMBH (DE) | 2020-12-08 | — | — | US | disclosed |
| CN-108291307-B | Plating bath composition and method for electroless plating of palladium | 埃托特克德国有限公司 | 2020-02-14 | — | — | CN | disclosed |
| US-10513780-B2 | Plating bath composition and method for electroless plating of palladium | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-12-24 | — | — | US | disclosed |
| EP-3380649-B1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-10-30 | — | — | EP | disclosed |
| CN-106661750-B | Acidic zinc and Zinc-nickel alloy electroplating bath composition and electro-plating method | 安美特德国有限公司 | 2019-01-29 | — | — | CN | disclosed |
| US-20180340260-A1 | PLATING BATH COMPOSITION AND METHOD FOR ELECTROLESS PLATING OF PALLADIUM | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2018-11-29 | — | — | US | disclosed |
| US-9309283-B2 | Prodrugs of peptide epoxy ketone protease inhibitors | ONYX THERAPEUTICS, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-20140105921-A1 | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors | ONYX THERAPEUTICS, INC. | 2014-04-17 | — | — | US | disclosed |
| EP-1517869-B1 | AIR-ENTRAINING ADMIXTURES | BCD ROHSTOFFE FUER BAUCHEMIE H (AT) | 2006-10-25 | — | — | EP | disclosed |
| EP-0291588-B1 | SIZING AGENT | KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) | 1991-09-04 | — | — | EP | disclosed |
| EP-0224976-B1 | METHOD OF SIZING PAPER | KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) | 1989-10-18 | — | — | EP | disclosed |
| US-4826570-A | PARTIAL ESTER OF ALKENYL SUCCINIC ACID, PAPERMAKING | KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) | 1989-05-02 | — | — | US | disclosed |
| EP-0291588-A1 | Sizing agent | KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) | 1988-11-23 | — | — | EP | disclosed |
| EP-0224976-A1 | Method of sizing paper | KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) | 1987-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140105921-A1 | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors | PREP, VIP, PEPD | TSHR 3808/4885APP 127/4885PTGS1 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.